Abstract
IntroductionThe incidence of pulmonary complications in immunocompromised patients is on the rise mainly driven by increased organ and bone marrow transplants, more aggressive chemotherapy and novel immunosuppressants.1 Mortality rates in...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have